Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

download

Hanmi Pharma shares crash after shock contract termination

September 30, 2016 Manufacturing and Production, Medical Communications, Research and Development Boehringer Ingelheim, Genentech, Germany, HM61713, Hanmi Pharmaceutical, Tagrisso, south korea

News broke on 29 September that Hanmi Pharma, South Korea’s leading drug maker, had signed a $910 million deal with …
News

NICE rejects Lilly lung cancer drug, recommends Bayer’s Xofigo and Amgen’s Imlygic

September 30, 2016 Medical Communications, Sales and Marketing Imlygic, NICE, Portrazza, xofigo

The National Institute of Health and Care Excellence has issued final guidance rejecting Eli Lilly’s Portrazza (necitumumab) for the treatment …
News
brian_mcnamara

GSK appoints Brian McNamara chief of consumer health division

September 29, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brian McNamara, Emma Walmsley, GlaxoSmithKline

GlaxoSmithKline PLC has named Brian McNamara the head of its consumer-health division. The new comes a week after the announcement …
Appointment
abbvie-singapore

AbbVie opens its $300 million manufacturing plant in Singapore

September 29, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Asia, Singapore

AbbVie’s new Singapore based manufacturing plant is expected to be fully operational by late 2018. The plant is expected to …
News

The October issue of Pharmafocus is now live!

September 29, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, Pharmafocus new issue

The latest edition of Pharmafocus is available online now.
News
janssen_stairs_1

Johnson & Johnson failed to inform FDA over faulty blood testing device in Phase III trial

September 29, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Johnson & Johnson, Xarelto, phase III, warfarin

The British Medical Journal, after its own investigation, found that Janssen knew early into the Phase III trial, known as …
News
novonordisk

Novo Nordisk to cut 2% of its entire workforce

September 29, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Denmark, Novo Nordisk, diabetes, insulin, job cuts, job losses

Novo Nordisk, headquartered in Bagsvaerd, Denmark, has taken the decision to lose 1,000 of its workforce from a total global …
News
eylea-product-box-md

NICE approves Bayer’s Eylea for NHS use

September 28, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Eylea, NICE

Bayer has announced that its Eylea (aflibercept) drug has received a final recommendation from NICE for the treatment of visual …
News

Merck elects Isabel De Paoli as CSO

September 27, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CSO, Merck, appointment

German pharma firm Merck has appointed Isabel De Paoli to the position of chief science officer in addition to her …
Appointment

CPHI Worldwide: PCI to Share Expertise in Serialization and Safe Handling of Potent Molecules

September 26, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CPhI

Leading pharmaceutical provider PCI Pharma Services will bring its expertise to the stage at CPHI Worldwide (Barcelona, October 4-6 2016) …
News
Press release

Merck elects Isabel De Paoli as CSO

September 26, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck, appointment

German pharma firm Merck has appointed Isabel De Paoli to the position of chief science officer in addition to her …
News

NICE approval for restricted-use hypophosphatasia therapy

September 23, 2016 Medical Communications, Sales and Marketing Alexion Pharmaceuticals, Strensiq, hypophosphatasia

The National Institute for Health and Care Excellence (NICE) has issued draft guidance recommending the use of Alexion Pharmaceutical’s Strensiq …
News
4420456374_64a3d7e6aa

Top ten stories in the pharmaceutical industry this week

September 23, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s Friday (and print day for the Pharmafocus October edition!) and its been a pretty explosive week, from new and …
News
alzheimers_brain

Alzheimer’s drug failure sends Lundbeck’s shares crashing

September 23, 2016 Medical Communications, Research and Development Alzheimer's, Lundbeck, cultural failings

Lundbeck’s experimental idalopirdine has failed to meet its primary endpoint in its first Phase III trial in the treatment of …
News
novo_nordisk_flag

Novo Nordisk to provide discounted insulin to poorest nations

September 23, 2016 Medical Communications, Sales and Marketing Novo Nordisk, diabetes, insulin

Danish pharma firm Novo Nordisk has announced its intention to provide insulin at discounted prices to the world’s poorest nations …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026